window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Development

  • Drug Development,Precision medicine

    Elkedonia raises EUR 11.25 million to develop new treatment for depression and other neuropsychiatric disorders

    New approach targets Elk1 to restore neuroplasticity without sedation or [...]

    June 12, 2025
  • Drug Development

    CN Bio expands liver-on-a-chip platform to include cross-species DILI models, enhancing IVIVE insights

    CN Bio has introduced two new animal-derived liver-on-a-chip models to [...]

    June 10, 2025
  • Drug Development

    Study shows bifunctional immunotherapy clears MDR Gram-negative bacteria in preclinical models

    CTX-09 demonstrates immune-mediated efficacy through Alphamer platform, supporting immune system [...]

    June 10, 2025
  • Artificial Intelligence,Regulatory Affairs,Technology and platforms

    FDA launches AI tool Elsa to boost internal efficiency and accelerate reviews

    The US Food and Drug Administration (FDA) has unveiled Elsa, [...]

    June 8, 2025
  • Artificial Intelligence,Clinical Trials,Drug Development,Technology and platforms

    Accelerating R&D in pharma: Inside Veeva’s mission to cut time-to-patient

    Stephan Ohnmacht, VP of R&D Business Consulting at Veeva Systems, [...]

    June 6, 2025
  • Cell & Gene Therapy,Clinical Trials,Drug Development

    MaaT Pharma submits EMA application for Xervyteg in graft-versus-host disease

    MaaT Pharma has submitted a marketing authorisation application (MAA) to [...]

    June 2, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy,Drug Development

    Fujifilm life sciences companies rebrand to strengthen end-to-end drug development solutions

    Fujifilm Corporation’s Life Sciences Group has rebranded its key companies [...]

    June 2, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Drug Delivery & Formulation,Drug Development

    Inside CTMC: Innovating cell therapy development from patient to clinic

    Cell therapy has emerged as one of the most promising [...]

    May 30, 2025
  • Clinical Trials,Drug Development,Regulatory Affairs

    Why patient-centric trial design is the future of oncology: Q&A with One2Treat’s chief medical officer Pascal Piedbois

    As oncology research continues to evolve, the focus is increasingly [...]

    May 30, 2025
  • Artificial Intelligence,Clinical Trials,Drug Development,Technology and platforms

    PhaseV and Crohn’s & Colitis Foundation join forces to fast-track IBD clinical trials with AI

    A new collaboration aims to tackle the toughest challenges in [...]

    May 28, 2025
Previous678Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Phesi data highlights 6.7% of global clinical trials affected by Middle East disruption
    Categories: Clinical Development, Clinical Trials, Data Management, Global health, Real world evidence
  • Genmab appoints Margarida Duarte as general manager for Europe and emerging markets
    Categories: Healthcare leadership, Mergers & Acquisitions, Movers & Shakers, Pharmaceuticals and therapeutics
  • Opella appoints former Reckitt executive Gonzalo Balcazar to lead Europe and Latin America
    Categories: Healthcare leadership, Market Access & Commercialization, Movers & Shakers, Pharmaceuticals and therapeutics, Startups and innovations
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top